GYNAECON 2026
Scientific Session
Fortis La Femme GYNAECON 2026: The Future of Women's Healthcare
4
Scientific sessions
19
Scheduled programme items
9 AM - 5 PM
Programme hours
About our presence
GYNAECON 2026, presented by Fortis La Femme, carried the theme 'The Future of Women's Healthcare' and the message 'Advancing Excellence in Women's Health.' Lemonaid Pharmaceuticals participated in the scientific gathering.
The programme ran on Sunday, 27 September 2026, with four scientific sessions scheduled from 9:00 AM to 5:00 PM. It covered labour pain relief, adolescent health, anaemia and birth outcomes, minimally invasive and robotic surgery, ovarian masses, endometriosis, infertility, menopause, precocious puberty, gestational diabetes and nutrition.
The schedule also included an inauguration ceremony, lunch and an evening tea break. The supplied programme does not specify the venue or Lemonaid's participation format.
Highlights
Obstetrics and adolescent health
Topics included pain relief in labour, changing scenarios of adolescence, birth outcomes beyond IFA, primary amenorrhoea and high-risk pregnancy.
Surgical practice
Sessions addressed complex and safe laparoscopy, robotic hysterectomy and the radiological assessment of ovarian masses.
Reproductive and midlife health
The programme covered endometriosis, infertility, sexual health in menopause and the mental load discussed in gynaecology consultations.
Women's health across life stages
Later sessions included precocious puberty, gestational diabetes, nutrition in the GLP-1 era and anaemia management in pregnancy.
Moments from GYNAECON 2026
0 glimpses · click any photo to enlarge